Optimal Sizing of Self-expanding Paclitaxel-eluting Stent for the Superficial Femoral Artery Lesion

Optimal Sizing of Self-expanding Paclitaxel-eluting Stent for the Superficial Femoral Artery Lesion - Optimal Sizing of Self-expanding Paclitaxel-eluting Stent for the Superficial Femoral Artery Lesion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023642

Enrollment

Registered

2016-11-01

Start date

2016-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriosclerosis Obliterans: ASO

Interventions

Implantation of stent with a 1mm larger diameter than the reference vessel Implantation of stent with a 2mm larger diameter than the reference vessel

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: De novo superficial femoral artery lesion

Exclusion criteria

Exclusion criteria: History of previous bypass surgery or previous stenting in the target lesion

Design outcomes

Primary

Measure	Time frame
Lumen area assessed by OFDI at 6-month follow-up	—

Secondary

Measure	Time frame
Minimum lumen diameter assessed by angiography at 6-month follow-up.	—

Countries

Japan

Contacts

Public ContactKojiro Miki

Hyogo College of Medicine Division of Cardiovascular Medicine and Coronary Heart Disease

hpxkg043@ybb.ne.jp0798-45-6553

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026